ArcticZymes Technologies - Board/Management Information 2020

Biotec Pharmacon ASA appoints Dr. Jethro Holter as CEO

(Tromsø 22. April 2020) Biotec Pharmacon ASA (OSE: "BIOTEC") announced today

that its Board of Directors has unanimously appointed Dr Jethro Holter as the

Company's permanent Chief Executive Officer. Dr Holter has been the interim CEO

for the last 6 months

Jethro joined ArcticZymes as Managing Director in January 2015. He focused on

driving a new strategic direction channelling the subsidiary's efforts towards

growth, through expanding its B2B client base and implementing a customer-driven

innovation approach for new product development. Consequently, the subsidiary

has experienced strong revenue growth and vastly expanded its portfolio of novel

enzyme products. Today, ArcticZymes is profitable and a leading commercial

supplier of enzymes to the molecular biology, In Vitro Diagnostics (IVD) and

gene therapy market segments. During his time as interim CEO, Jethro has

implemented a new Group strategy and continued to drive healthy growth in the

business.

"The Board of Directors is pleased to announce Jethro Holter as the CEO for

Biotec Pharmacon ASA going forward. After being hired as the interim CEO 6

months ago, the Board is confident he has the necessary skills and background

required to drive the company into profitability and long-term value creation.",

says Chairman of the Board Dr Marie Roskrow

"I am delighted in being appointed CEO. It is an exciting time to lead this

company which is in a transition phase with a fresh and inspiring strategic

direction. With the talented team behind me, I am confident we can aspire to

maximise growth and transform the company into becoming Europe's leading one

-stop-shop for enzymes. As the newly appointed CEO, my first priority will be to

drive the company into profitability.", says CEO Jethro Holter

The Company will present its Q1 2020 results tomorrow morning at 0830

For further information, please contact:

Jethro HolterHethro Marie Roskrow

CEO Chairman of the Board

+47 46 85 91 46 Mobile: +44 (0) 7496 959743

AI assistant